Meta Biomed Co., Ltd. (KOSDAQ:059210)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,040.00
0.00 (0.00%)
At close: Feb 19, 2026

Meta Biomed Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
134,90984,85299,71852,83266,18464,352
Market Cap Growth
42.83%-14.91%88.74%-20.17%2.85%-0.69%
Enterprise Value
136,81295,997130,45376,54689,58996,285
Last Close Price
4985.003686.844297.172265.792810.672712.24
PE Ratio
8.103.799.8920.116.95-
PS Ratio
1.350.901.200.771.131.43
PB Ratio
1.110.881.370.831.101.30
P/TBV Ratio
1.140.931.460.911.161.38
P/FCF Ratio
35.417.24--7.3024.43
P/OCF Ratio
7.783.759.765.775.9413.24
EV/Sales Ratio
1.371.021.571.111.522.14
EV/EBITDA Ratio
4.674.328.808.3010.1414.92
EV/EBIT Ratio
5.735.5712.3014.2717.0338.30
EV/FCF Ratio
35.918.19--9.8836.55
Debt / Equity Ratio
0.360.580.610.700.571.01
Debt / EBITDA Ratio
1.532.533.004.783.907.73
Debt / FCF Ratio
11.524.79--3.8018.95
Net Debt / Equity Ratio
0.010.020.380.390.310.58
Net Debt / EBITDA Ratio
0.040.081.862.702.104.47
Net Debt / FCF Ratio
0.320.16-21.74-4.002.0510.96
Asset Turnover
0.570.610.660.620.560.43
Inventory Turnover
2.412.732.992.652.101.58
Quick Ratio
1.070.940.710.750.760.70
Current Ratio
1.551.281.121.141.201.10
Return on Equity (ROE)
17.64%26.25%14.74%4.61%17.37%-5.92%
Return on Assets (ROA)
8.33%7.00%5.28%2.99%3.12%1.49%
Return on Invested Capital (ROIC)
16.75%16.52%11.24%6.28%6.70%3.07%
Return on Capital Employed (ROCE)
18.90%16.60%12.40%7.00%8.10%4.20%
Earnings Yield
13.62%26.40%10.11%4.97%14.39%-6.36%
FCF Yield
2.82%13.81%-1.27%-11.80%13.70%4.09%
Dividend Yield
0.60%0.81%0.46%0.88%0.71%0.37%
Payout Ratio
1.80%2.04%4.54%17.43%2.40%-
Buyback Yield / Dilution
32.66%-18.55%0.06%0.07%0.61%1.08%
Total Shareholder Return
33.25%-17.74%0.53%0.95%1.32%1.45%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.